AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
Currently predicting for Fri, 24 May 2024

Trading levels for OVID

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.52 9.08 %
R2 3.42 5.77 %
R1 3.35 3.72 %
Current price: 3.23
Support S1 3.14 -2.90 %
S2 3.07 -4.94 %
S3 2.96 -8.26 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.43 6.19 %
R2 3.40 5.26 %
R1 3.34 3.41 %
Current price 3.23
Support S1 3.20 -0.93%
S2 3.05 -5.57%
S3 2.79 -13.62%

OVID Predictions History

4 years ago
Zev Rosenblum predicted that OVID for 2020-01-03 is going

Rank:

4 years ago
2poJeff predicted that OVID for 2019-12-26 is going $4.83 (-4.55%)

4 years ago
Derrick Barker predicted that OVID for 2019-12-26 is going

Rank:

5 years ago
NameNotImportant predicted that OVID for 2019-05-06 is going $1.89 (-11.68%)

5 years ago
NameNotImportant predicted that OVID for 2019-05-02 is going $1.80 (0.56%)

Click to get the best stock tips daily for free!

About Ovid Therapeutics Inc

Ovid Therapeutics Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule... OVID Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT